Concepedia

Dmitri B. Kirpotin

DB

Statistics

Publications

57

Citations

7.9K

H-Index

39

Active since

1989

Affiliations

University of California, San Francisco(Current)

California Pacific Medical Center

Merrimack Pharmaceuticals (United States)

Hermes Microvision (United States)

Neurological Surgery

Dmitri B. Kirpotin is an author at University of California, San Francisco specializing in drug delivery, pharmacy, and nanomedicine.

Publications per year

1989–2022

57

Publications

57

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Dmitri B. Kirpotin, Daryl C. Drummond, Yi Shao et al. · Cancer Research · 2006 · 1.1K citations · Full text

Pharmacy, Cancer Biology, Molecular Pharmaceutics +17

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park, Keelung Hong, Dmitri B. Kirpotin et al. · PubMed · 2002 · 648 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells <i>in Vitro</i>

Dmitri B. Kirpotin, John W. Park, Keelung Hong et al. · Biochemistry · 1997 · 441 citations

Pharmacy, Oncology, Pharmacology +17

Epidermal Growth Factor Receptor–Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs<i>In vivo</i>

Christoph Mamot, Daryl C. Drummond, Charles O. Noble et al. · Cancer Research · 2005 · 380 citations

Pharmacy, Oncology, Pharmacology +17

Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy

Daryl C. Drummond, Charles O. Noble, Zexiong Guo et al. · Cancer Research · 2006 · 375 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 57